Traditional approach preventive HIV vaccines: What are the cell substrate and inactivation issues?

AIDS Research and Human Retroviruses

Volumn 14, Issue 7, 1998, Pages 627-633

  Sheets, R L ^a   Goldenthal, K L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VIRUS VACCINE; RECOMBINANT PROTEIN;

ANIMAL CELL; CONFERENCE PAPER; CONTINUOUS CULTURE; CONTROLLED STUDY; DRUG INDUSTRY; DRUG SAFETY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR CELL LINE; VACCINATION; VACCINE PRODUCTION; VIRION; VIRUS CELL TRANSFORMATION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS PURIFICATION; VIRUS TITRATION;

EID: 0032080397     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.627     Document Type: Conference Paper

References (37)